688 related articles for article (PubMed ID: 15477396)
1. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.
Gage BF; van Walraven C; Pearce L; Hart RG; Koudstaal PJ; Boode BS; Petersen P
Circulation; 2004 Oct; 110(16):2287-92. PubMed ID: 15477396
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.
Hart RG; Pearce LA; McBride R; Rothbart RM; Asinger RW
Stroke; 1999 Jun; 30(6):1223-9. PubMed ID: 10356104
[TBL] [Abstract][Full Text] [Related]
3. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation.
Pearce LA; Hart RG; Halperin JL
Am J Med; 2000 Jul; 109(1):45-51. PubMed ID: 10936477
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation and cardioembolic stroke.
Ferro JM
Minerva Cardioangiol; 2004 Apr; 52(2):111-24. PubMed ID: 15194993
[TBL] [Abstract][Full Text] [Related]
5. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.
Arch Intern Med; 1994 Jul; 154(13):1449-57. PubMed ID: 8018000
[TBL] [Abstract][Full Text] [Related]
7. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.
JAMA; 1998 Apr 22-29; 279(16):1273-7. PubMed ID: 9565007
[TBL] [Abstract][Full Text] [Related]
8. Lessons from the Stroke Prevention in Atrial Fibrillation trials.
Hart RG; Halperin JL; Pearce LA; Anderson DC; Kronmal RA; McBride R; Nasco E; Sherman DG; Talbert RL; Marler JR;
Ann Intern Med; 2003 May; 138(10):831-8. PubMed ID: 12755555
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
You JJ; Singer DE; Howard PA; Lane DA; Eckman MH; Fang MC; Hylek EM; Schulman S; Go AS; Hughes M; Spencer FA; Manning WJ; Halperin JL; Lip GYH
Chest; 2012 Feb; 141(2 Suppl):e531S-e575S. PubMed ID: 22315271
[TBL] [Abstract][Full Text] [Related]
10. [Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
Gandjour J; Zeindler J; Georgiadis D; Baumgartner RW
Praxis (Bern 1994); 2005 Jan; 94(4):97-104. PubMed ID: 15732803
[TBL] [Abstract][Full Text] [Related]
11. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.
Gage BF; Waterman AD; Shannon W; Boechler M; Rich MW; Radford MJ
JAMA; 2001 Jun; 285(22):2864-70. PubMed ID: 11401607
[TBL] [Abstract][Full Text] [Related]
12. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies.
Hart RG; Pearce LA; Miller VT; Anderson DC; Rothrock JF; Albers GW; Nasco E
Cerebrovasc Dis; 2000; 10(1):39-43. PubMed ID: 10629345
[TBL] [Abstract][Full Text] [Related]
13. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
Guo Y; Wang H; Tian Y; Wang Y; Lip GYH
Chest; 2015 Jul; 148(1):62-72. PubMed ID: 25501045
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients.
Hess CN; Broderick S; Piccini JP; Alexander KP; Newby LK; Shaw LK; Mahaffey KW; Alexander JH; Peterson ED; Granger CB; Lopes RD
Am Heart J; 2012 Oct; 164(4):607-15. PubMed ID: 23067921
[TBL] [Abstract][Full Text] [Related]
16. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for stroke prevention in patients with atrial fibrillation.
Howard PA
Drugs; 1999 Dec; 58(6):997-1009. PubMed ID: 10651387
[TBL] [Abstract][Full Text] [Related]
18. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
Agarwal S; Hachamovitch R; Menon V
Arch Intern Med; 2012 Apr; 172(8):623-31; discussion 631-3. PubMed ID: 22450212
[TBL] [Abstract][Full Text] [Related]
19. Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials.
Akins PT; Feldman HA; Zoble RG; Newman D; Spitzer SG; Diener HC; Albers GW
Stroke; 2007 Mar; 38(3):874-80. PubMed ID: 17255547
[TBL] [Abstract][Full Text] [Related]
20. Long-term antithrombotic treatment for atrial fibrillation.
Nademanee K; Kosar EM
Am J Cardiol; 1998 Oct; 82(8A):37N-42N. PubMed ID: 9809899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]